ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,199.50
-0.77%
US Tech 100
17,410.80
0.12%
Dow Jones
38,763.45
0.00%
Brent Oil
77.975
-0.52%
Bitcoin
57,139.67
3.83%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. Italy
  5. BIT

  6. UniCredit Bank AG (UV8CBZ) Quote

UniCredit Bank AG

UniCredit Bank AG (UV8CBZ)

BIT
0.00
0.00
( 0.00% )
Updated: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

UV8CBZ Latest News

More News

Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024

BASKING RIDGE, N.J., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative...

August 05 2024
GlobeNewswire Inc.

Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy

BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, and Lisata Therapeutics, Inc. (Nasdaq: LSTA), a...

July 18 2024
GlobeNewswire Inc.

Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma

Complete enrollment achieved nearly six months ahead of plan Top-line data now anticipated mid-2025 Addition of second-line cholangiocarcinoma arm to BOLSTER trial BASKING RIDGE, N.J., July 16...

July 16 2024
GlobeNewswire Inc.

Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model

BASKING RIDGE, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative...

July 10 2024
GlobeNewswire Inc.

Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial

Phase 1b/2a open-label trial in the U.S. of certepetide in combination with neoadjuvant FOLFIRINOX based therapies in pancreatic, colon and appendiceal cancers BASKING RIDGE, N.J., June 13, 2024...

June 13 2024
GlobeNewswire Inc.

Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events

BASKING RIDGE, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative...

May 28 2024
GlobeNewswire Inc.

Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer

Waiver confirms that paediatric studies of certepetide in pancreatic cancer are not needed Significant clinical trial burden and costs avoided due to waiver BASKING RIDGE, N.J., May 20, 2024...

May 20 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

May 10 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 09 2024
Edgar (US Regulatory)

Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Seminal Phase 2b ASCEND trial top-line data expected in fourth quarter of 2024 Projected available cash to fund planned operations into early 2026 covering all studies through data Conference...

May 09 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CDTConduit Pharmaceuticals Inc
$ 0.4139
(150.85%)
68.14M
CMPXCompass Therapeutics Inc
$ 1.31
(45.56%)
88
HROWHarrow Inc
$ 30.9991
(41.03%)
13.03k
MSGMMotorsport Games Inc
$ 2.04
(37.84%)
4
WENAANEW MEDICAL INC
$ 1.50
(37.61%)
16.23M
CDLXCardlytics Inc
$ 3.07
(-55.51%)
442.24k
OMOutset Medical Inc
$ 2.05
(-39.71%)
28.6k
BMBLBumble Inc
$ 4.87
(-39.58%)
1.2M
VIRXViracta Therapeutics Inc
$ 0.2744
(-38.97%)
1.27k
GNLNGreenlane Holdings Inc
$ 2.73
(-32.59%)
18.18k
CDTConduit Pharmaceuticals Inc
$ 0.4139
(150.85%)
68.14M
XPONExpion360 Inc
$ 0.104
(24.55%)
55.41M
WENAANEW MEDICAL INC
$ 1.50
(37.61%)
16.23M
ADDColor Star Technology Company Ltd
$ 0.388
(-22.38%)
7.68M
SQQQProShares UltraPro Short QQQ
$ 10.81
(-0.18%)
5.86M

Discussion

View Full Feed
fredscott36 fredscott36 3 minutes ago
......USCA/2 is on vacation for most of AUGUST....???......so we is gonna be here awhile........

....further, any DECISION will be some form of "continuance".....remand, simple send back due to amended petition, clarification and/or related.......

....accordingly, MORE
toohot toohot 3 minutes ago
ed, NOPAIN ACT, will be another positive to look forward to in this amazing BIEL journey.




BUY $BIEL$
BIEL
cottonmather cottonmather 4 minutes ago
Tidbits: FBI has been raiding homes of the lesser known fact tellers. Scott Ritter maybe the most recent. These people usually have a conservative lean/


I met this fella a few days ago. Seems like an okay guy. 4 minutes https://youtu.be/RpxdNahXq84?si=Lh8wV1qvwIIQexbX
Thomas@yahoo Thomas@yahoo 4 minutes ago
Wise Wolf 🐺, Competitor: CHARLOTTES WEB
http://archive.fast-edgar.com/20240808/AW2ZV22CZ222R2Z22226224OQU76ZK229V62/
CVSI
jammy32 jammy32 4 minutes ago
Does anyone have details on the MIKAH deal ? Any facts at all.
ELTP
€LL-$G7$ €LL-$G7$ 4 minutes ago
Down 10% premarket..
Mightvjump ship at 10
UVIX
Jahvik Jahvik 4 minutes ago
https://x.com/authentichldgs/status/1821518285428367683?s=46
AHRO
KISSINGER KISSINGER 4 minutes ago
Hmmm where are the bashers? The first of two major contracts and one is a $12 Billion public company? Yup if you can bash that then U have lost the credibility you never had anyhow.
AHRO
TAZMANS TAZMANS 5 minutes ago
$AHRO Huge! NEWS Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement

Source: InvestorsHub NewsWire

Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement

Somerville, NJ
AHRO
reena969 reena969 5 minutes ago
$40k spent $1278.67 made. Time to Short. Should have stayed with my OTC play .0004 -.0013 exit
jaws57 jaws57 5 minutes ago
FYI, NG storage report @10:30 today. Weekly job claims @8:30
OmegaMoney29 OmegaMoney29 5 minutes ago
Wowowowo drop
NVDA
oilfieldmafia oilfieldmafia 5 minutes ago
Things sure do look good here.....
ASKE
looking 4 a win looking 4 a win 6 minutes ago
I agree, it just looks too risky. I don’t mind gambling a little but it could go either direction quick. Premarket is sideways.
UVIX
jaws57 jaws57 6 minutes ago
Im in also. Bgt near close Y.
Right now In BOIL/SQQQ/SPXS one pos ea.
SQQQ
i_like_bb_stock i_like_bb_stock 6 minutes ago
CNSP back over .20 moving easier here another MAXN type move off bottom with alot less shares diluted
CNSP MAXN
i_like_bb_stock i_like_bb_stock 7 minutes ago
CNSP back over .20 moving easier here another MAXN type move off bottom with alot less shares diluted
CNSP MAXN
dexprs dexprs 7 minutes ago
https://seekingalpha.com/article/4710516-8-percent-yielding-reit-preferred-shares?mailingid=36339055&messageid=2850&serial=36339055.7450&source=email_2850&utm_campaign=rta-author-article&utm_medium=email&utm_source=seeking_alpha&utm_term=36339055.7450
plugger plugger 7 minutes ago
Please feel free to tell me I am all wet, I don't care----but as I read this early this morning I thought----" how lazy many have become, we take what the guy in the pulpit tells us to be the truth, even if we wonder if it is wrong or right, we think in Sunday School that the author of our lesson m
reena969 reena969 8 minutes ago
LGCL dodge a bullet .
GBR GBR 8 minutes ago
They kept referring to further cost and revenue synergies in 2nd half 2024. Maybe now that this agreement has been announced, they are in the position to provide better guidance instead of remaining "very conservative".
VERI
chazzy1 chazzy1 8 minutes ago
All we can do now is wait. Staring at the clock (or at the stock price) only makes the time pass more slowly. Worrying about things over which we have no control makes no sense either, as it is an expenditure of negative energy. We are like the farmer who has planted his seed. Now, we hope and pray
HDVY
Jetmek_03052 Jetmek_03052 9 minutes ago
DBMM is a "CULT" stock. Buy at your peril!

This is not likely to rise above the present price without ACTUAL business improvements. There's no "naked short" position to drive this.

No REAL investor would take a chance on this company. Gamblers? Sure.

Peo
DBMM
jedijazz jedijazz 9 minutes ago
$CBDW Chatbots in Investor Relations: A New Era of Efficient Communication and How 1606 Corp (CBDW) is Leading the Way on the OTC @CBDWInc https://cbdw.ai/chatbots-in-investor-relations-a-new-era-of-efficient-communication-and-how-1606-corp-cbdw-is-leading-the-way-on-the-otc/
#MSFT #AI #IRCha
CBDW MSFT
2morrowsGains 2morrowsGains 9 minutes ago
BKTI...A Big thumbs up to those that hold👍...I missed out on this one...🙄

Your Recent History

BIT
UV8CBZ
UniCredit Bank
ASX
ICGNB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved